These effects were sustained after a 4-week recovery period, with the exception of a restoration of MCH projections to baseline levels, indicating a long-lasting, chronic effect that can impact balance of sleep–wake cycles and potentially be further exacerbated in individuals presenting with AD neuropathology [196]. This evidence concerns the gene PMCH and Alzheimer disease.